Claybrook Capital’s Clorox CLX Stock Holding History

Claybrook Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,507	Closed	-$271K	–	147
2021 Q2	$271K	Buy	+1,507	New	+$275K	0.09%	144
2019 Q1	–	Sell	-5	Closed	-$1K	–	181
2018 Q4	$1K	Buy	+5	New	+$779	﹤0.01%	681

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Claybrook Capital's CLX Position: Q3 2021 in Review

Claybrook Capital sold out of Clorox (CLX) in Q3 2021, closing a stake of 1,507 shares — an estimated $271K sold.

Claybrook Capital first reported a position in CLX in Q4 2018 and held it in 2 quarters. The position peaked at $271K in Q2 2021. 1,134 funds tracked by Wall St. Rank hold CLX as of Q3 2021.

Claybrook Capital reported no remaining Clorox position as of Q3 2021 after selling out during the quarter.
Claybrook Capital sold 1,507 Clorox shares in Q3 2021, an estimated $271K.
Claybrook Capital first reported a position in Clorox in Q4 2018 and held it in 2 quarters.
Claybrook Capital's Clorox position peaked at $271K in Q2 2021.
1,134 funds tracked by Wall St. Rank held Clorox as of Q3 2021.

Based on Claybrook Capital's 13F filing for Q3 2021, filed 15 Nov 2021.